NCT00087737View on ClinicalTrials.gov

Study Evaluating DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

369

Participants

Timeline

Start Date

Not specified

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions
Major Depressive Disorder
Interventions
DRUG

DVS-233 SR

DRUG

Venlafaxine ER

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00087737 - Study Evaluating DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive Disorder | Biotech Hunter | Biotech Hunter